Clinical Trials Directory

Trials / Completed

CompletedNCT05987995

Is it Safe to do Endometrial Injury in the Same ICSI Cycle: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Accepted

Summary

Endometrial injury is one of the interventions suggested to improve the endometrial receptivity by enhancing the decidualization process, and so increasing the pregnancy rate

Detailed description

In assisted reproductive techniques , specially ICSI, several approaches have been put forward to improve the endometrium, including endometrial injection of granulocyte colony-stimulating factor or platelet-rich plasma. Endometrial injury is one of the interventions suggested to improve the endometrial receptivity. Endometrial injury, also known as endometrial scratching, is the intentional damage of the endometrium, usually using a pipelle, aiming at increasing the implantation rate. The exact mechanism of action is still vague ,many hypotheses have been advocated, including enhanced decidualization, which is stimulated by the local injury. Moreover, endometrial injury stimulates an inflammatory response, which in turn adjusts gene expression. The value of endometrial injury is a controversial issue, there is no agreement on the exact time to perform endometrial scratching, so in the current study, we investigated the safety and efficacy of performing endometrial injury in the follicular phase of the same ICSI cycle.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndometrial injuryA pipelle endometrial sampler was introduced gently into the uterine cavity. The inner piston of the catheter was withdrawn to create suction, and injury (scratching) of the endometrium was done by moving the pipelle catheter up and down within the uterine cavity

Timeline

Start date
2022-09-11
Primary completion
2023-01-20
Completion
2023-01-20
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05987995. Inclusion in this directory is not an endorsement.